Adial Pharmaceuticals, Inc.

ADIL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016
Assets
Cash & Equivalents $18.2K $88.0K
Accounts Receivable
Inventory
Total Current Assets $27.2K
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill) $7.3K
Total Assets $34.5K
Liabilities
Accounts Payable
Total Current Liabilities $1.0M
Long-Term Debt
Total Liabilities $1.0M
Stockholders' Equity
Retained Earnings $-404.0K
Total Stockholders' Equity $-997.6K $-103.5K
← Newer Page 2 of 2 Older →